Sort
27,075 grants matching “cholesterol”
Task Area B2 Visit 3 Basic Exam.
$1,001,740Robert Kaplan · Albert Einstein College Of Medicine · N01 · FY2020 · HL
Indianapolis-Ibadan Dementia Project
$1,001,527Kathleen S Hall · Indiana Univ-Purdue Univ At Indianapolis · R01 · FY2007 · AG
Cellular and Developmental Biology of Coxiella burnetii
$1,000,403Robert A Heinzen · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Discovery and Validation of a Novel Response Biomarker Signature for Painful Peripheral Neuropathy
$1,000,168Mikhail I. Nemenov · Lasmed, Llc · R61 · FY2022 · NS
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2019 · TS
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2021 · TS
Human Stem Cell Model of Niemann Pick Type C
$1,000,000Lawrence S Goldstein · University Of California, San Diego · RC1 · FY2010 · NS
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · SB1 · FY2019 · AI
Molecular Biomedical Imaging Laboratory
$1,000,000David Bluemke · National Institute Of Biomedical Imaging And Bioengineering · ZIA · FY2010 · EB
Assessment of PFAS exposures and health effects in two Massachusetts communities with PFAS drinking water contamination
$1,000,000Laurel A. Schaider · Silent Spring Institute · U01 · FY2020 · TS
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · SB1 · FY2017 · AI
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
$1,000,000Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2013 · AI
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
$1,000,000Richard W Scott · Fox Chase Chemical Diversity Center, Inc · R44 · FY2014 · AI
Therapeutic D-peptide Inhibitor of HIV Entry
$1,000,000Alan L Mueller · Navigen, Inc. · SB1 · FY2018 · AI
Development of Small Antimicrobial Peptide Mimics as Drug-Resistant and Susceptib
$1,000,000Richard W Scott · Polymedix, Inc, · R44 · FY2012 · AI
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians
$999,998Pradeep Natarajan · Massachusetts General Hospital · U01 · FY2021 · HG
Targeting lipid rafts for treatment of asthma
$999,991Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2023 · AI
Novel biologic to treat chemotherapy-induced neuropathic pain
$999,967Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2022 · CA
Low-Cost Instrument-free Point-of-Care Test for Chlamydia and Gonorrhea
$999,228Debkishore Mitra · Lucira Health, Inc · R44 · FY2020 · AI
Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis
$998,631Kathryn J Moore · New York University School Of Medicine · R35 · FY2019 · HL
Protein Misfolding and Aggregation
$998,496Jennifer Lee · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
DIET AND GENOTYPE IN PRIMATE ATHEROSCLEROSIS
$997,715John L Vandeberg · Texas Biomedical Research Institute · P51 · FY2009 · RR
Motor proteins and cytoskeletal dynamics in lymphocytes, melanocytes and neurons
$997,625John A Hammer · National Heart, Lung, And Blood Institute · ZIA · FY2018 · HL
Targeting lipid rafts for treatment of asthma
$997,203Yakov Kogan · Raft Pharmaceuticals, Llc · R44 · FY2024 · AI
Enabling improved applicability and transferability of polygenic scores across diverse populations- a focus on South Asians
$996,075Pradeep Natarajan · Massachusetts General Hospital · U01 · FY2022 · HG